Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PERFECT CHOICE 0.717% ROOT AND DENTIN DESENS .14 %

HYDROGEN FLUORIDE : .14 % STANNOUS FLUORIDE : .4 % SODIUM FLUORIDE : 1.09 % · DIN 02044951 · CHALLENGE PRODUCTS INC.

Health Canada status: CANCELLED POST MARKET

What is PERFECT CHOICE 0.717% ROOT AND DENTIN DESENS?

PERFECT CHOICE 0.717% ROOT AND DENTIN DESENS .14 % contains HYDROGEN FLUORIDE : .14 % STANNOUS FLUORIDE : .4 % SODIUM FLUORIDE : 1.09 %. It is listed in the Health Canada Drug Product Database under DIN 02044951, held by CHALLENGE PRODUCTS INC., supplied as LIQUID for DENTAL administration. Health Canada currently lists it as cancelled post market, status dated 27-Jul-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02044951
Brand namePERFECT CHOICE 0.717% ROOT AND DENTIN DESENS
Generic / active ingredientHYDROGEN FLUORIDE : .14 % STANNOUS FLUORIDE : .4 % SODIUM FLUORIDE : 1.09 %
ManufacturerCHALLENGE PRODUCTS INC.
Strength.14 %
Dosage formLIQUID
Route of administrationDENTAL
ScheduleNON-PRESCRIPTION DRUGS
ATC codeA01AA30 COMBINATION (CARIES PROPHYLACTIC AGENTS)
AHFS class34:00.00
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date27-Jul-2001
Original market date1996-08-28 00:00:00

What can be used instead?

Other Canadian products sharing ATC code A01AA30 COMBINATION (CARIES PROPHYLACTIC AGENTS). 0 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
ACIDULATED PHOSPHATE FLUORIDE ORAL SOLUTION.017 %SOLUTIONPDT IMAGE INC. DBA PRO-DENTEC CANADACANCELLED POST MARKETDIN 02117339
PASCAL PUFF1.23 %LIQUIDPASCAL INTERNATIONAL CORPORATIONCANCELLED POST MARKETDIN 02241675
PDF GEL 1.24%1.24 %GELLAB BMG INC.CANCELLED POST MARKETDIN 00461024

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02044951. Last reviewed 2026-09-09. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.